Obesity and Kidney Disease: Hidden Consequences of the EpidemicCsaba P. Kövesdy, Carmine Zoccali, Susan L. Furth|American Journal of Nephrology|2017Cited by 2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyCarmine Zoccali, Rainer H. Böger, Stefanie M. Bode‐Böger et al.|The Lancet|2001Cited by 1.1k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaPiero Ruggenenti, Giuseppe Remuzzi, Annalisa Perna et al.|The Lancet|1999Cited by 909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseasesKitty J. Jager, Carmine Zoccali, Csaba P. Kövesdy et al.|Kidney International|2019Cited by 886
An introduction to inverse probability of treatment weighting in observational researchNicholas C Chesnaye, Kitty J. Jager, Vianda S Stel et al.|Clinical Kidney Journal|2021Cited by 877